JNCE - Jounce Therapeutics Q3 2022 Earnings Preview
- Jounce Therapeutics ( NASDAQ: JNCE ) is scheduled to announce Q3 earnings results on Thursday, November 10th, before market open.
- The consensus EPS Estimate is -$0.64
- Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward.
For further details see:
Jounce Therapeutics Q3 2022 Earnings Preview